Blume Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-900	Closed	-$14K	–	228
2018 Q4	$14K	Buy	+900	New	+$14K	0.01%	177